USTR Accepting Comments for Medical-Care Products to be Removed from Section 301 Actions due to COVID-19 Outbreak

Polsinelli
Contact

Polsinelli

On March 25, 2020, the Office of the U.S. Trade Representative (USTR) published a Federal Register Notice requesting public comments on possible further modifications to remove Section 301 duties from additional Chinese-origin medical-care products. The USTR invites comments from interested persons with respect to whether a particular product covered by Section 301 duties on Chinese goods is needed to respond to the COVID-19 outbreak. The comment docket will remain open at least until June 25, 2020, and may be extended as appropriate.

The USTR is requesting that each comment identify the particular product of concern and explain precisely how the product relates to the response to the COVID-19 outbreak. For example, a comment may address whether a product is directly used to treat COVID-19 or to limit the outbreak, and/or whether the product is used in the production of needed medical-care products.

The USTR is accepting comments regarding any product covered by the Section 301 duties, regardless of whether the product is subject to a pending or denied exclusion request.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Polsinelli | Attorney Advertising

Written by:

Polsinelli
Contact
more
less

Polsinelli on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.